Our top pick for
Ocean Bio-Chem Inc is a conglomerates business based in the US. Ocean Bio-Chem shares (OBCI) are listed on the NASDAQ and all prices are listed in US Dollars. Ocean Bio-Chem employs 192 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.45|
|52-week range||$8.20 - $17.86|
|50-day moving average||$9.52|
|200-day moving average||$11.57|
|Wall St. target price||N/A|
|Dividend yield||$0.1 (1.05%)|
|Earnings per share (TTM)||$1.06|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||5.05%|
|1 month (2021-09-16)||11.68%|
|3 months (2021-07-16)||-10.28%|
|6 months (2021-04-16)||-16.98%|
|1 year (2020-10-16)||-23.37%|
|2 years (2019-10-16)||211.10%|
|3 years (2018-10-16)||161.97%|
|5 years (2016-10-14)||291.49%|
Valuing Ocean Bio-Chem stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ocean Bio-Chem's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ocean Bio-Chem's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Ocean Bio-Chem shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ocean Bio-Chem's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.3 million.
The EBITDA is a measure of a Ocean Bio-Chem's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$60.9 million|
|Operating margin TTM||21.2%|
|Gross profit TTM||$23.5 million|
|Return on assets TTM||16.23%|
|Return on equity TTM||25.63%|
|Market capitalisation||$94.4 million|
TTM: trailing 12 months
There are currently 48,826 Ocean Bio-Chem shares held short by investors – that's known as Ocean Bio-Chem's "short interest". This figure is 39.9% up from 34,891 last month.
There are a few different ways that this level of interest in shorting Ocean Bio-Chem shares can be evaluated.
Ocean Bio-Chem's "short interest ratio" (SIR) is the quantity of Ocean Bio-Chem shares currently shorted divided by the average quantity of Ocean Bio-Chem shares traded daily (recently around 17192.253521127). Ocean Bio-Chem's SIR currently stands at 2.84. In other words for every 100,000 Ocean Bio-Chem shares traded daily on the market, roughly 2840 shares are currently held short.
However Ocean Bio-Chem's short interest can also be evaluated against the total number of Ocean Bio-Chem shares, or, against the total number of tradable Ocean Bio-Chem shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ocean Bio-Chem's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ocean Bio-Chem shares in existence, roughly 10 shares are currently held short) or 0.0162% of the tradable shares (for every 100,000 tradable Ocean Bio-Chem shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ocean Bio-Chem.
Find out more about how you can short Ocean Bio-Chem stock.
Dividend payout ratio: 13.18% of net profits
Recently Ocean Bio-Chem has paid out, on average, around 13.18% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ocean Bio-Chem shareholders could enjoy a 1.21% return on their shares, in the form of dividend payments. In Ocean Bio-Chem's case, that would currently equate to about $0.1 per share.
While Ocean Bio-Chem's payout ratio might seem low, this can signify that Ocean Bio-Chem is investing more in its future growth.
Ocean Bio-Chem's most recent dividend payout was on 22 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 7 September 2021 (the "ex-dividend date").
Ocean Bio-Chem's shares were split on a 11:10 basis on 24 September 2002. So if you had owned 10 shares the day before before the split, the next day you'd have owned 11 shares. This wouldn't directly have changed the overall worth of your Ocean Bio-Chem shares – just the quantity. However, indirectly, the new 9.1% lower share price could have impacted the market appetite for Ocean Bio-Chem shares which in turn could have impacted Ocean Bio-Chem's share price.
Over the last 12 months, Ocean Bio-Chem's shares have ranged in value from as little as $8.2043 up to $17.8594. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ocean Bio-Chem's is 0.3852. This would suggest that Ocean Bio-Chem's shares are less volatile than average (for this exchange).
Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, home care, and outdoor power equipment markets in the United States and Canada. The company offers marine products, including polishes, cleaners, protectants, waxes, enzyme fuel treatments, private label products, motor and teak oils, boat washes, vinyl and teak cleaners, bilge and hull cleaners, silicone and polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants; and brushes, brush handles, tie-downs, and other related accessories. It also manufactures automotive products, such as fuel treatments for gas and diesel engines, motor oils, greases, and related items; anti-freeze and windshield washes; and automotive polishes, cleaners, and other items. In addition, the company offers fuel treatment and other specialty products to the recreational vehicle market; solutions to various problems associated with E-10 fuel; and other specialty recreational vehicle/power sports products, including cleaners, polishes, detergents, fabric cleaners and protectors, silicone sealants, waterproofers, gasket materials, degreasers, vinyl cleaners and protectors, toilet treatment fluids, and anti-freeze/coolants. Further, it provides solutions to rectify operating engine problems in commercial lawn, and other home and garden power equipment; deodorizers, disinfectants, and sanitizers, as well as mildew odor control bags and boat odor sanitizers; blends and packages chemical formulations; and manufactures PVC and HDPE blow molded bottles. The company sells its products under the Star Tron, Performacide, and Star brite brands through retailers and online retailers, as well as to distributors.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.